Capricor Therapeutics, Inc

(NASDAQ:CAPR)

Latest On Capricor Therapeutics, Inc (CAPR):

Date/Time Type Description Signal Details
2023-05-12 07:12 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 17:36 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.96M beats by $0.96MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q4 2022 Earnings Call TranscriptN/A
2023-03-14 18:00 ESTNewsCapricor Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-25 14:41 ESTNewsCapricor stock falls amid data for duchenne muscular dystrophy studyN/A
2022-11-11 07:18 ESTNewsCapricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45MN/A
2022-11-11 07:17 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 21:36 ESTNewsCapricor Therapeutics Q3 2022 Earnings PreviewN/A
2022-08-12 00:03 ESTNewsCapricor stock rises 16% after update on muscular dystrophy treatment, Q2 resultsN/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics GAAP EPS of -$0.29 misses by $0.03N/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2022 Results Earnings Call TranscriptN/A
2022-08-09 20:06 ESTNewsCapricor Therapeutics Q2 Earnings PreviewN/A
2022-06-28 01:00 ESTNewsCapricor posts statistically significant data for DMD candidate in open-label trialN/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics GAAP EPS of -$0.32N/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-28 16:40 ESTNewsCapricor Therapeutics down 24% following COVID-19 mid-stage trial results (updated)N/A
2022-03-11 08:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban On Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-25 10:04 ESTNewsCapricor jumps 12% after CAP-1002 commercialization deal in U.S. for treatment of DMDN/A
2021-12-13 16:39 ESTNewsCapricor Therapeutics provides key updates on its COVID-19 vaccine programsN/A
2021-11-10 04:09 ESTNewsCapricor Therapeutics EPS beats by $0.06N/A
2021-11-10 04:08 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 05:10 ESTNewsCapricor Therapeutics Q3 2021 Earnings PreviewN/A
2021-09-25 19:24 ESTNewsCapricor Therapeutics Announces Another 'Final' 12-Month P2 Duchenne Muscular Dystrophy Trial ResultN/A
2021-09-24 23:37 ESTNewsCapricor jumps 17% on positive CAP-1002 data from mid-stage duchenne muscular dystrophy studyN/A
2021-09-02 16:11 ESTNewsCapricor shares up 6 % as it will present final data on muscular dystrophy candidate late SeptemberN/A
2021-08-13 10:16 ESTNewsCapricor Therapeutics EPS beats by $0.02, misses on revenueN/A
2021-08-13 10:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-20 22:51 ESTNewsCapricor Therapeutics slumps 9% on $75M stock offeringN/A
2021-04-30 07:24 ESTNewsCapricor shares rise on license agreement with Johns Hopkins UniversityN/A
2021-03-18 04:19 ESTFinancialsCompany financials have been released.Neutral
2021-03-13 03:16 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 07:18 ESTEarnings EstimateAn EPS average of -$1.07 is estimated for the 2022 year.Sell
2021-03-12 00:43 ESTNewsCapricor Therapeutics EPS misses by $0.01N/A
2021-03-12 00:43 ESTNewsCapricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-09 13:49 ESTNewsCapricor Therapeutics updates on COVID-19 vaccine pre-clinical studyN/A
2021-02-10 08:09 ESTNewsCapricor Therapeutics - Shockingly Undervalued With Imminent Catalysts In PlayN/A
2021-02-01 10:47 ESTNewsCapricor signs intellectual property license for COVID-19 serology test platformN/A
2021-01-25 03:17 ESTAnalyst RatingThe Analyst Target Price has increased from $10.5 to $12.Buy
2021-01-20 01:02 ESTNewsCapricor announces positive findings from collaboration with Cedars-Sinai Medical Center researchersN/A
2021-01-12 20:54 ESTNewsCapricor and Lonza tie up in DMD developmentN/A
2020-12-13 03:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:54 ESTNewsDosing underway in Capricor Therapeutics' mid-stage CAP-1002 study in COVID-19N/A
2020-11-18 03:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 03:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 22:56 ESTNewsCapricor Therapeutics, Inc's (CAPR) CEO Linda Marbán on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-12 19:06 ESTNewsCapricor Therapeutics reports Q3 resultsN/A
2020-11-01 17:26 ESTFinancialsCompany financials have been released.Neutral

About Capricor Therapeutics, Inc (CAPR):

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. The company's development stage drug candidates for cardiosphere-derived cells include CAP-1002, a cardiac cell derived therapy, which is in phase II clinical trial for the treatment of patients with late-stage DMD; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of inflammatory conditions. Capricor collaborates with Lonza for the development of CAP-1002, its cell therapy candidate for the treatment of Duchenne muscular dystrophy and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California.

See Advanced Chart

General

  • Name Capricor Therapeutics, Inc
  • Symbol CAPR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:10
  • Last Split Date2019-06-05
  • Fiscal Year EndDecember
  • IPO Date2007-02-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.capricor.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 149.52
  • Price/Book (Most Recent Quarter) 4.13
  • Enterprise Value Revenue 190.86
  • Enterprise Value EBITDA 0.03
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.00
  • Next Year EPS Estimate -$1.06
  • Operating Margin -4413%
  • Return on Assets -37%
  • Return on Equity -78%
  • Revenue 310250
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.02
  • Gross Profit -8146750
  • Quarterly Earnings Growth -74%
View More

Highlights

  • Market Capitalization 118.78 million
  • EBITDA -11929662
  • Analyst Target Price $12
  • Book Value Per Share $1.37
View More

Share Statistics

  • Shares Outstanding 22.8 million
  • Shares Float 19.99 million
  • % Held by Insiders 253%
  • % Held by Institutions 6.2%
  • Shares Short 345150
  • Shares Short Prior Month 489136
  • Short Ratio 0.36
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 6.47
  • 52 Week High $12.32
  • 52 Week Low $0.96
  • 50 Day Moving Average 6.37
  • 200 Day Moving Average 5.05
View More

Dividends

  • Dividend Date 2019-06-05
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Capricor Therapeutics, Inc (CAPR) Dividend Calendar:

CAPR's last dividend payment was made to shareholders on June 5, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Capricor Therapeutics, Inc (CAPR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.21-$0.20-5%
2020-09-302020-11-12$N/A-$0.20-$0.3745.95%
2020-06-302020-08-06$N/A-$0.23-$0.3432.35%
2020-03-312020-05-13$185693-$0.30-$0.3616.67%
2019-12-312020-03-18$222100-$0.34-$0.340%
2019-09-302019-11-07$142071-$0.43-$0.6836.76%
2019-06-302019-08-06$410353-$0.59-$0.8026.25%
2019-03-312019-05-13$230504-$0.80-$1.1027.27%
2018-12-312019-03-28$648082-$1.10-$1.6031.25%
2018-09-302018-11-13$219247-$1.40-$1.453.45%
2018-06-302018-08-09$403960-$1.40-$1.25-12%
2018-03-312018-05-10$400066-$1.40-$1.20-16.67%
2017-12-312018-03-14$475000$4.20-$1.00520%
2017-09-302017-11-08$314000-$1.20-$1.9036.84%
2017-06-302017-08-10$996000-$1.60-$1.8011.11%
2017-03-312017-05-15$881000-$1.70-$1.50-13.33%
2016-12-312017-03-15$907000-$2.10-$2.7022.22%
2016-09-302016-11-10$747000-$2.90-$2.65-9.43%
2016-06-302016-08-15$1.13 million-$2.60-$2.40-8.33%
2016-03-312016-05-12$1.22 million-$2.60-$1.90-36.84%
2015-12-312016-03-17$1.12 million-$2.10-$1.90-10.53%
2015-09-302015-11-12$1.32 million-$0.18-$0.2630.77%
2015-06-302015-08-13$1.29 million-$0.19-$0.2626.92%
2015-03-312015-05-12$1.79 million-$0.23-$0.14-64.29%
2014-12-312015-03-16$1.4 million-$0.16-$0.13-23.08%
2014-09-302014-11-14$1.3 million-$0.13-$0.2240.91%
2014-06-302014-08-14$1.04 million-$1.31
2014-03-312014-05-15$1.04 million-$1.04
2013-12-312014-03-17$503233-$6.39
2013-09-302013-11-15$80000-$4.02
2013-06-302013-08-15$190000-$6.94
2013-03-312013-06-21$233000-$5.61
2012-12-312013-03-12$2.03 million-$2.39
2012-09-302012-11-12$-2423235-$6.57
2012-06-302012-08-13$N/A-$4.11
2012-03-312012-05-15$195500-$20.00-$15.00-33.33%
2011-12-312012-03-13-$22.29
2011-09-302011-11-14$813000-$15.00-$7.50-100%
2011-06-302011-08-15$346000-$15.00-$5.00-200%
2011-03-312011-05-16-$15.00-$10.00-50%
2010-12-312011-03-14-$10.00-$21.6753.85%
2010-09-302010-11-12-$25.00-$23.33-7.16%
2010-06-302010-08-16-$25.00-$33.3324.99%
2010-03-312010-05-14-$35.00-$28.33-23.54%
2009-12-312010-03-03-$30.00-$25.00-20%
2009-09-302009-11-12-$40.00-$25.00-60%
2009-06-302009-08-13-$50.00-$37.50-33.33%
2009-03-312009-05-14-$35.00-$58.3340%
2008-12-312009-03-09-$60.00-$65.007.69%
2008-09-302008-11-13-$70.00-$78.3310.63%
2008-06-302008-08-14-$80.00-$57.50-39.13%
2008-03-312008-05-15-$65.00-$55.00-18.18%
2007-12-312008-03-13-$50.00-$95.0047.37%
2007-09-302007-11-28-$173.63
2006-12-312006-12-31-$6.69
2006-09-302006-09-30-$23.16
2006-06-302006-06-30-$5.98
2006-03-312006-03-31-$4.79
2005-09-302005-09-30-$2.28
2005-06-302005-06-30-$1.95
2005-03-312005-03-31-$3.57
2004-12-312004-12-31-$6.14
2004-09-302004-09-30-$2.33
2004-06-302004-06-30-$1.90
2004-03-312004-03-31-$1.64
2003-12-312003-12-31-$3.57
2003-09-302003-09-30-$0.06
2003-06-302003-06-30-$4.61
2003-03-312003-03-31-$2.46
2002-12-312002-12-31-$2.50
2002-09-302002-09-30-$5.67
2002-06-302002-06-30-$6.25

Capricor Therapeutics, Inc (CAPR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 1.16 million 828749
Income Before Tax N/A N/A N/A -2.08 million -1.47 million
Selling General Administrative N/A N/A N/A 1.14 million 876720
Gross Profit N/A N/A N/A N/A 222100
Ebit N/A N/A N/A -2.07 million -1.48 million
Operating Income N/A N/A N/A -2.11 million -1.48 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A 185693 222100
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A 22690 13951
Net Income From Continuing Operations N/A N/A N/A -2.08 million -1.47 million
Net Income Applicable to Common Shares -4.18 million -3.91 million -3.48 million N/A -1.47 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities N/A N/A 426904 N/A N/A
Total Cash Flow from Investing Activities N/A N/A 5.99 million N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A N/A N/A
Change to Operating Activities N/A N/A 149635 N/A N/A
Change in Cash N/A N/A N/A N/A N/A
Total Cash from Operating Activities N/A N/A -1.22 million N/A N/A
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A N/A 287807 N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A 5.78 million 5.47 million N/A N/A
Total Stockholder Equity N/A 30.41 million 31.65 million N/A N/A
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets N/A 36.19 million 37.13 million N/A N/A
Common Stock 20577 20212 N/A 9189 N/A
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -88.04 million -83.86 million N/A -76.47 million N/A
Other Liabilities 3.38 million 3.38 million N/A 3.38 million N/A
Other Assets 88701 88701 N/A 107380 N/A
Cash N/A N/A N/A N/A N/A
Total Current Liabilities 2.97 million 2.28 million N/A N/A N/A
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 850847 603719 N/A 410913 N/A
Total Current Assets 33.68 million 35.49 million 36.25 million N/A N/A
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 28.2 million 30.4 million 9.59 million 9.59 million N/A
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.72 million 2.06 million N/A N/A N/A

Capricor Therapeutics, Inc (CAPR) Chart:

Capricor Therapeutics, Inc (CAPR) News:

Below you will find a list of latest news for Capricor Therapeutics, Inc (CAPR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Capricor Therapeutics, Inc (CAPR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-202.57.82CALL0 14743.92TRUE00
2025-06-2059.1CALL10 109368.55TRUE10.12
2025-06-207.56.2CALL1 391193.12TRUE0.50.09
2025-06-20104.3CALL204 2291114.63TRUE1.070.33
2025-06-2012.51.8CALL1870 416150.93TRUE0.610.51
2025-06-20150.56CALL631 521480.47FALSE0.311.24
2025-06-2017.50.17CALL828 166393.88FALSE0.070.7
2025-06-20200.09CALL168 853114.25FALSE0.090
2025-06-2022.50.05CALL1 498128.56FALSE00
2025-06-20250CALL0 264212.98FALSE00
2025-06-20300CALL0 1871172.15FALSE00
2025-06-20350CALL0 367245.07FALSE00
2025-06-20400.04CALL30 3126238.98FALSE0.040
2025-06-202.50PUT0 516427.79FALSE00
2025-06-2050.03PUT0 202332.12FALSE00
2025-06-207.50.05PUT20 1224187.65FALSE00
2025-06-20100.15PUT107 605145.16FALSE00
2025-06-2012.50.3PUT7 102791.94FALSE-0.35-0.54
2025-06-20152.3PUT0 32762.36TRUE00
2025-06-2017.57.53PUT0 32380.81TRUE00
2025-06-20200PUT0 206100.62TRUE00
2025-06-2022.50PUT0 65171.3TRUE00
2025-06-20250PUT0 60186.88TRUE00
2025-06-20300PUT0 0387.58TRUE00
2025-06-20350PUT0 0223.36TRUE00
2025-06-20400PUT0 0502.52TRUE00
2025-07-182.58.4CALL0 0359.5TRUE00
2025-07-1856.65CALL0 355325.27TRUE00
2025-07-187.54.2CALL0 0192.28TRUE00
2025-07-18104.6CALL30 433103.62TRUE0.70.18
2025-07-1812.53.2CALL52 170123.89TRUE0.50.19
2025-07-18152.1CALL216 514125.78FALSE0.30.17
2025-07-1817.51.55CALL392 20137.12FALSE0.230.17
2025-07-18200CALL0 0135.1FALSE00
2025-07-1822.50.75CALL31 10141.29FALSE0.750
2025-07-182.50PUT0 0268.8FALSE00
2025-07-1850.2PUT0 32282.69FALSE00
2025-07-187.50.55PUT0 20177.9FALSE00
2025-07-18100.82PUT24 195149.56FALSE-0.28-0.25
2025-07-1812.52.15PUT1612 228168.2FALSE-0.43-0.17
2025-07-18153.5PUT43 2162.69TRUE-0.9-0.2
2025-07-1817.58.25PUT0 0158.57TRUE00
2025-07-18200PUT0 0161.59TRUE00
2025-07-1822.50PUT0 0182.58TRUE00
2025-08-152.50CALL0 0590.41TRUE00
2025-08-1550CALL0 0242.94TRUE00
2025-08-157.50CALL0 0160.67TRUE00
2025-08-15106.57CALL1231 2101202.05TRUE0.970.17
2025-08-1512.54.81CALL1 300219.73TRUE4.810
2025-08-15155.22CALL1312 1934228.5FALSE0.870.2
2025-08-1517.54.2CALL28 0213.49FALSE4.20
2025-08-15203.67CALL104 5214.76FALSE0.70.24
2025-08-1522.53.1CALL50 0210.52FALSE3.10
2025-08-152.50PUT0 0256.9FALSE00
2025-08-1550.75PUT54 779251.75FALSE-0.02-0.03
2025-08-157.51.7PUT205 598245.61FALSE-0.05-0.03
2025-08-15103.05PUT1222 1964248.01FALSE-0.05-0.02
2025-08-1512.54.7PUT26 46253.25FALSE4.70
2025-08-15156.5PUT28 1256.57TRUE6.50
2025-08-1517.50PUT0 0278.15TRUE00
2025-08-152010.2PUT11 0251.65TRUE10.20
2025-08-1522.50PUT0 0238.06TRUE00
2025-09-192.50CALL0 2221.38TRUE00
2025-09-1959.31CALL2 5788.7TRUE9.310
2025-09-197.57.4CALL0 560183.75TRUE00
2025-09-19106.9CALL43 1902179.24TRUE0.90.15
2025-09-1912.56CALL7 2130184.17TRUE0.60.11
2025-09-19155.5CALL211 5555195.7FALSE0.70.15
2025-09-1917.54.52CALL85 328184.18FALSE0.520.13
2025-09-19204.3CALL82 4762195.37FALSE0.710.2
2025-09-1922.53.2CALL0 189194.02FALSE00
2025-09-19253.4CALL16 920193.75FALSE0.80.31
2025-09-19302.7CALL535 1665191.35FALSE0.50.23
2025-09-192.50.3PUT22 1965249.66FALSE-0.01-0.03
2025-09-1951.05PUT1076 2091235.7FALSE-0.06-0.05
2025-09-197.52.4PUT503 1081245.38FALSE0.10.04
2025-09-19103.6PUT11 920230.13FALSE-0.1-0.03
2025-09-1912.55.2PUT19 2302228.7FALSE-0.2-0.04
2025-09-19157.3PUT20 580241.52TRUE7.30
2025-09-1917.50PUT0 69230.19TRUE00
2025-09-192010.75PUT10 18225.85TRUE-0.47-0.04
2025-09-1922.50PUT0 8219.43TRUE00
2025-09-192516.3PUT0 16219.59TRUE00
2025-09-193018.7PUT1 0208.64TRUE18.70
2025-12-192.50CALL0 0202.06TRUE00
2025-12-1959.5CALL6 151696.16TRUE0.90.1
2025-12-197.58.1CALL13 2553124.91TRUE8.10
2025-12-19107.2CALL10 5812139.85TRUE0.90.14
2025-12-1912.56.5CALL10 764148.14TRUE10.18
2025-12-19155.45CALL704 617140.37FALSE0.450.09
2025-12-1917.53.98CALL0 4633144.34FALSE00
2025-12-19200CALL0 636152.84FALSE00
2025-12-1922.53CALL0 3150.45FALSE00
2025-12-19253CALL0 217143.01FALSE00
2025-12-192.50PUT0 110445.17FALSE00
2025-12-1951.61PUT0 429155.22FALSE00
2025-12-197.50PUT0 3185.65FALSE00
2025-12-19104.02PUT0 4525183.02FALSE00
2025-12-1912.55.8PUT0 240190.29FALSE00
2025-12-19157.6PUT9 0187.9TRUE7.60
2025-12-1917.510.05PUT0 507159.01TRUE00
2025-12-19200PUT0 0183.69TRUE00
2025-12-1922.50PUT0 0183.79TRUE00
2025-12-19250PUT0 0177.63TRUE00
2026-01-162.57.8CALL0 12172.86TRUE00
2026-01-1658.1CALL0 10199.99TRUE00
2026-01-167.56.8CALL0 4273120.68TRUE00
2026-01-16107.24CALL188 2306131.63TRUE1.240.21
2026-01-1612.56.5CALL2 402138.13TRUE10.18
2026-01-16155CALL0 541136FALSE00
2026-01-1617.53.75CALL0 108137.05FALSE00
2026-01-16202.5CALL0 125139.12FALSE00
2026-01-1622.50CALL0 331135.86FALSE00
2026-01-16252.78CALL0 24134.58FALSE00
2026-01-16303.07CALL19 1535138.11FALSE3.070
2026-01-162.50PUT0 278288.11FALSE00
2026-01-1650PUT0 192180.78FALSE00
2026-01-167.52.57PUT51 208185.33FALSE2.570
2026-01-16104.35PUT0 1207182.48FALSE00
2026-01-1612.50PUT0 1703202.78FALSE00
2026-01-16150PUT0 258195.23TRUE00
2026-01-1617.50PUT0 197170.95TRUE00
2026-01-16200PUT0 251170.26TRUE00
2026-01-1622.50PUT0 0171.71TRUE00
2026-01-16250PUT0 0169.54TRUE00
2026-01-163019.92PUT2 46175.58TRUE19.920
2027-01-152.58CALL0 285.39TRUE00
2027-01-1559.85CALL15 65567.67TRUE0.650.07
2027-01-157.57.2CALL0 257781.03TRUE00
2027-01-15107.57CALL2 99184.55TRUE1.270.2
2027-01-1512.57.5CALL2 42575.97TRUE7.50
2027-01-15156.2CALL25 6890.06FALSE0.50.09
2027-01-1517.50CALL0 28190.37FALSE00
2027-01-15200CALL0 10790.03FALSE00
2027-01-1522.52.7CALL0 2692.23FALSE00
2027-01-15253.28CALL0 18792.81FALSE00
2027-01-15303.85CALL120 89294.13FALSE3.850
2027-01-152.50PUT0 540FALSE00
2027-01-1552PUT0 12144.18FALSE00
2027-01-157.50PUT0 14127.02FALSE00
2027-01-15104.85PUT2 112131.37FALSE4.850
2027-01-1512.56.45PUT3 143127.53FALSE6.450
2027-01-15150PUT0 14130.3TRUE00
2027-01-1517.50PUT0 0130.42TRUE00
2027-01-152012PUT0 47120.41TRUE00
2027-01-1522.50PUT0 0127.96TRUE00
2027-01-15250PUT0 0120.45TRUE00
2027-01-15300PUT0 0128.59TRUE00

Latest CAPR Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST62$3.88
Jun 13, 2022 7:58 PM EST5$3.8
Jun 13, 2022 7:59 PM EST100$3.8
Jun 13, 2022 7:59 PM EST100$3.79
Jun 13, 2022 7:59 PM EST50$3.79

Capricor Therapeutics, Inc (CAPR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2018-10-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000018034036/0000000000-18-034036-index.htm
2019-12-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000019016215/0000000000-19-016215-index.htm
2020-05-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000020004293/0000000000-20-004293-index.htm
2019-12-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133869/000091957419007837/0000919574-19-007837-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919061080/0001104659-19-061080-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919061773/0001104659-19-061773-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919063785/0001104659-19-063785-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919064252/0001104659-19-064252-index.htm
2019-12-05S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919070066/0001104659-19-070066-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072396/0001104659-19-072396-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072626/0001104659-19-072626-index.htm
2019-12-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465919072629/0001104659-19-072629-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073161/0001104659-19-073161-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073600/0001104659-19-073600-index.htm
2019-12-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919074049/0001104659-19-074049-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074247/0001104659-19-074247-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022098/0001104659-20-022098-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/0001104659-20-022099-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/0001104659-20-022100-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022101/0001104659-20-022101-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022102/0001104659-20-022102-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022103/0001104659-20-022103-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022104/0001104659-20-022104-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022105/0001104659-20-022105-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022110/0001104659-20-022110-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920031538/0001104659-20-031538-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920034994/0001104659-20-034994-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920035320/0001104659-20-035320-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920038468/0001104659-20-038468-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000110465920039272/0001104659-20-039272-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920047790/0001104659-20-047790-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920056292/0001104659-20-056292-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920056303/0001104659-20-056303-index.htm
2020-05-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465920058189/0001104659-20-058189-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920058192/0001104659-20-058192-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060449/0001104659-20-060449-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060930/0001104659-20-060930-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920061570/0001104659-20-061570-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062419/0001104659-20-062419-index.htm
2020-05-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062458/0001104659-20-062458-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920062698/0001104659-20-062698-index.htm
2020-05-19424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920063822/0001104659-20-063822-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920066994/0001104659-20-066994-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071410/0001104659-20-071410-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071413/0001104659-20-071413-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071415/0001104659-20-071415-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071417/0001104659-20-071417-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071419/0001104659-20-071419-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071420/0001104659-20-071420-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071421/0001104659-20-071421-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071423/0001104659-20-071423-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071426/0001104659-20-071426-index.htm
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920091413/0001104659-20-091413-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920092415/0001104659-20-092415-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920098381/0001104659-20-098381-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2017-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053252/0001144204-17-053252-index.htm
2017-10-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417053253/0001144204-17-053253-index.htm
2017-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2017-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417057263/0001144204-17-057263-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417058512/0001144204-17-058512-index.htm
2017-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417059277/0001144204-17-059277-index.htm
2017-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417061266/0001144204-17-061266-index.htm
2017-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417063248/0001144204-17-063248-index.htm
2017-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417064330/0001144204-17-064330-index.htm
2017-12-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417065088/0001144204-17-065088-index.htm
2018-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000266/0001144204-18-000266-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000853/0001144204-18-000853-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000854/0001144204-18-000854-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000856/0001144204-18-000856-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000857/0001144204-18-000857-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000859/0001144204-18-000859-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000860/0001144204-18-000860-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000861/0001144204-18-000861-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000862/0001144204-18-000862-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000863/0001144204-18-000863-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000864/0001144204-18-000864-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000865/0001144204-18-000865-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2018-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418005594/0001144204-18-005594-index.htm
2018-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418009043/0001144204-18-009043-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014063/0001144204-18-014063-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014635/0001144204-18-014635-index.htm
2018-03-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420418016468/0001144204-18-016468-index.htm
2018-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418022479/0001144204-18-022479-index.htm
2018-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418025173/0001144204-18-025173-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418027107/0001144204-18-027107-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418027786/0001144204-18-027786-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418033770/0001144204-18-033770-index.htm
2018-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418039922/0001144204-18-039922-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418043267/0001144204-18-043267-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418043686/0001144204-18-043686-index.htm
2018-10-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420418055035/0001144204-18-055035-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418056889/0001144204-18-056889-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418059340/0001144204-18-059340-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418059980/0001144204-18-059980-index.htm
2018-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418066148/0001144204-18-066148-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419000167/0001144204-19-000167-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419002173/0001144204-19-002173-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419005129/0001144204-19-005129-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419016629/0001144204-19-016629-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419016787/0001144204-19-016787-index.htm
2019-04-0110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419017194/0001144204-19-017194-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419020402/0001144204-19-020402-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419022029/0001144204-19-022029-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419025600/0001144204-19-025600-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419026041/0001144204-19-026041-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029338/0001144204-19-029338-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029669/0001144204-19-029669-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419031589/0001144204-19-031589-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034627/0001144204-19-034627-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034690/0001144204-19-034690-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034770/0001144204-19-034770-index.htm
2019-07-17S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420419034954/0001144204-19-034954-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419035262/0001144204-19-035262-index.htm
2019-07-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419035263/0001144204-19-035263-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419037875/0001144204-19-037875-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419038387/0001144204-19-038387-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038994/0001144204-19-038994-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038995/0001144204-19-038995-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038996/0001144204-19-038996-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038997/0001144204-19-038997-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038998/0001144204-19-038998-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038999/0001144204-19-038999-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039000/0001144204-19-039000-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039001/0001144204-19-039001-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419040654/0001144204-19-040654-index.htm
2019-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419042160/0001144204-19-042160-index.htm
2019-08-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419042161/0001144204-19-042161-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419047446/0001144204-19-047446-index.htm
2019-07-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519001637/9999999995-19-001637-index.htm
2019-12-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519002841/9999999995-19-002841-index.htm
2020-05-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999520001205/9999999995-20-001205-index.htm
2018-04-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718004982/9999999997-18-004982-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718007502/9999999997-18-007502-index.htm

Capricor Therapeutics, Inc (CAPR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Capricor Therapeutics, Inc (CAPR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 253%
Institutional Ownership: 620%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-10-23Louis ManzoDirectorBuy20,748.000.163,319.68159,132.00https://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2019-12-17Frank LitvackDirectorBuy20,391.0020,391.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2017-12-22Rachel SmithVice President of R&DBuy20,748.000.163,319.6820,748.00https://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2019-12-17David B MusketDirectorBuy20,391.0022,891.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-17Louis ManzoDirectorBuy20,391.0036,304.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2020-09-24Louis ManzoDirectorBuy8,299.003.7030,706.3044,603.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2020-07-27Linda MarbanCHIEF EXECUTIVE OFFICERBuy41,497.003.70153,538.9062,367.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm